The global pulse oximeter market is expected to grow at a compound annual growth rate (CAGR) of approximately 7% during the forecast period. This growth is primarily driven by the rising incidence of ...

A federal jury in California ruled Friday that Apple must pay medical device maker Masimo $634 million for infringing a ...

In a landmark decision, Masimo Corp. has emerged victorious in its high-stakes patent litigation against Apple Inc., receiving a staggering $634 million verdict. This case, closely monitored by ...

Amid its multi-front legal battle with Apple over its smartwatch’s blood oxygen sensors, Masimo has claimed new ...

A federal jury has ruled in favor of Masimo, finding that the Apple Watch infringed on the company’s pulse-oximetry patent ...

Masimo scored a significant legal victory over Apple in the latest installment of the long-running legal battle between the ...

Apple has suffered a major defeat in its long-term legal dispute with the medtech firm Masimo and has been ordered to pay ...

Apple said it plans to appeal the verdict, which could delay Masimo’s collection of the damages by as much as two years, one ...

Apple has been ordered to pay $634 million to medical device maker Masimo after a federal jury in California concluded that features built into the Apple Watch infringed on one of Masimo’s ...

Apple's $634M Masimo patent loss highlights wearables IP risks and blurs the lines between consumer devices and medical ...

On Nov. 14, 2025, 4D Advisors, LLC disclosed in a regulatory filing that it sold out its entire position in Masimo ( MASI 0.92%). The sale was valued at $7.57 million.

In the latest chapter of the legal war between Apple and Masimo, a federal jury has ordered the former to pay $634 million in ...